IMRX – immuneering corporation - class a (US:NASDAQ)
Stock Stats
News
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
We Think Immuneering (NASDAQ:IMRX) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Immuneering Recognizes Melanoma Awareness Month [Yahoo! Finance]
Form 10-Q Immuneering Corp For: Mar 31
Form 8-K Immuneering Corp For: May 07
Form DEFA14A Immuneering Corp
Form DEF 14A Immuneering Corp For: Apr 23
Form SC 13G/A Immuneering Corp Filed by: Cormorant Asset Management, LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.